Efficacy of Prednisone In the Treatment of Ocular Myasthenia
NCT00995722
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class
Stopped
Slow recruitment rate
Conditions
Ocular Myasthenia Gravis
Interventions
DRUG:
Prednisone
DRUG:
Placebo
Sponsor
Michael Benatar
Collaborators
[object Object]
[object Object]